Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2020;31(3):319-24
Article Links
Nutritional Pearls: Diet and Rheumatoid Arthritis
Panagiotis Athanassiou1, Lambros Athanassiou2, Ifigenia Kostoglou-Athanassiou3
Authors Information

1. Department of Rheumatology, St. Paul’s Hospital, Thessaloniki, Greece

2. Department of Physiology, Medical School, University of Athens, Greece

3. Department of Endocrinology, Asclepeion Hospital, Voula, Athens, Greece

Panagiotis Athanassiou, Ifigenia Kostoglou-Athanassiou 

Keywords: diet, rheumatoid arthritis, fasting, Mediterranean diet, Cretan Mediterranean diet, vegetarian diet, obesity, flavonoids, resveratrol, curcumin
References
  1. Skoldstam L, Larsson L, Lindstrom FD. Effect of fasting and lactovegetarian diet on rheumatoid arthritis. Scand J Rheumatol 1979;8(4):249-255.
  2. McKellar G, Morrison E, McEntegart A, Hampson R, Tierney A, Mackle G, et al. A pilot study of a Mediterranean-type diet intervention in female patients with rheumatoid arthritis living in areas of social deprivation in Glasgow. Ann Rheum Dis 2007;66(9):1239-43.
  3. Skoldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann Rheum Dis 2003;62(3):208-14.
  4. Asteriou E, Gkoutzourelas A, Mavropoulos A, Katsiari C, Sakkas LI, Bogdanos DP. Curcumin for the Management of Periodontitis and Early ACPA-Positive Rheumatoid Arthritis: Killing Two Birds with One Stone. Nutrients 2018;10(7).
  5. Yang G, Chang CC, Yang Y, Yuan L, Xu L, Ho CT, et al. Resveratrol Alleviates Rheumatoid Arthritis via Reducing ROS and Inflammation, Inhibiting MAPK Signaling Pathways, and Suppressing Angiogenesis. J Agric Food Chem 2018;66(49):12953-60.
  6. Yang CM, Chen YW, Chi PL, Lin CC, Hsiao LD. Resveratrol inhibits BK-induced COX-2 transcription by suppressing acetylation of AP-1 and NF-kappaB in human rheumatoid arthritis synovial fibroblasts. Biochem Pharmacol 2017;132:77-91.
  7. Bustamante MF, Agustin-Perez M, Cedola F, Coras R, Narasimhan R, Golshan S, et al. Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis. Contemp Clin Trials Commun 2020;17:100524.
  8. Vadell AKE, Barebring L, Hulander E, Gjertsson I, Lindqvist HM, Winkvist A. Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity. Am J Clin Nutr 2020 Feb 13. pii: nqaa019.
  9. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Laerum E, Eek M, Mowinkel P, et al. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis. Lancet 1991;338(8772):899-902.
  10. Kjeldsen-Kragh J, Haugen M, Borchgrevink CF, Forre O. Vegetarian diet for patients with rheumatoid arthritis--status: two years after introduction of the diet. Clin Rheumatol 1994;13(3):475-82.
  11. Muller H, de Toledo FW, Resch KL. Fasting followed by vegetarian diet in patients with rheumatoid arthritis: a systematic review. Scand J Rheumatol 2001;30(1):1-10.
  12. Sundqvist T, Lindstrom F, Magnusson KE, Skoldstam L, Stjernstrom I, Tagesson C. Influence of fasting on intestinal permeability and disease activity in patients with rheumatoid arthritis. Scand J Rheumatol 1982;11(1):33-8.
  13. Skoldstam L, Magnusson KE. Fasting, intestinal permeability, and rheumatoid arthritis. Rheum Dis Clin North Am 1991;17(2):363-71.
  14. Fraser DA, Thoen J, Djoseland O, Forre O, Kjeldsen-Kragh J. Serum levels of interleukin-6 and dehydroepiandrosterone sulphate in response to either fasting or a ketogenic diet in rheumatoid arthritis patients. Clin Exp Rheumatol 2000;18(3):357-62.
  15. Fraser DA, Thoen J, Selvaag AM, Djoseland O, Forre O, Kjeldsen-Kragh J. A preliminary study of circadian serum cortisol concentrations in response to a 72-hour fast in rheumatoid arthritis patients not previously treated with corticosteroids. Clin Rheumatol 2001;20(2):85-87.
  16. Fraser DA, Thoen J, Reseland JE, Forre O, Kjeldsen-Kragh J. Decreased CD4+ lymphocyte activation and increased interleukin-4 production in peripheral blood of rheumatoid arthritis patients after acute starvation. Clin Rheumatol 1999;18(5):394-401.
  17. Choi IY, Lee C, Longo VD. Nutrition and fasting mimicking diets in the prevention and treatment of autoimmune diseases and immunosenescence. Mol Cell Endocrinol 2017;455:4-12.
  18. Minelli P, Montinari MR. The Mediterranean Diet And Cardioprotection: Historical Overview And Current Research. J Multidiscip Healthc 2019;12:805-15.
  19. Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, et al. Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev 2019;3:Cd009825.
  20. Forsyth C, Kouvari M, D'Cunha NM, Georgousopoulou EN, Panagiotakos DB, Mellor DD, et al. The effects of the Mediterranean diet on rheumatoid arthritis prevention and treatment: a systematic review of human prospective studies. Rheumatol Int 2018;38(5):737-47.
  21. Johansson K, Askling J, Alfredsson L, Di Giuseppe D. Mediterranean diet and risk of rheumatoid arthritis: a population-based case-control study. Arthritis Res Ther 2018;20(1):175.
  22. Hu Y, Costenbader KH, Gao X, Hu FB, Karlson EW, Lu B. Mediterranean diet and incidence of rheumatoid arthritis in women. Arthritis Care Res (Hoboken) 2015;67(5):597-606.
  23. Porras M, Rada G, Duran J. Effects of Mediterranean diet on the treatment of rheumatoid arthritis. Medwave 2019;19(5):e7640.
  24. Winkvist A, Barebring L, Gjertsson I, Ellegard L, Lindqvist HM. A randomized controlled cross-over trial investigating the effect of anti-inflammatory diet on disease activity and quality of life in rheumatoid arthritis: the Anti-inflammatory Diet In Rheumatoid Arthritis (ADIRA) study protocol. Nutr J 2018;17(1):44.
  25. Philippou E, Nikiphorou E. Are we really what we eat? Nutrition and its role in the onset of rheumatoid arthritis. Autoimmun Rev 2018;17(11):1074-7.
  26. Smedslund G, Byfuglien MG, Olsen SU, Hagen KB. Effectiveness and safety of dietary interventions for rheumatoid arthritis: a systematic review of randomized controlled trials. J Am Diet Assoc. 2010;110(5):727-735.
  27. Hu Y, Costenbader KH, Gao X, Al-Daabil M, Sparks JA, Solomon DH, et al. Sugar-sweetened soda consumption and risk of developing rheumatoid arthritis in women. Am J Clin Nutr 2014;100(3):959-67.
  28. Sawani A, Farhangi M, N CA, Maul TM, Parthasarathy S, Smallwood J, et al. Limiting Dietary Sugar Improves Pediatric Sinonasal Symptoms and Reduces Inflammation. J Med Food 2018;21(6):527-34.
  29. Izaola O, de Luis D, Sajoux I, Domingo JC, Vidal M. [Inflammation and obesity (lipoinflammation)]. Nutr Hosp 2015;31(6):2352-8.
  30. Scarpellini E, Tack J. Obesity and metabolic syndrome: an inflammatory condition. Dig Dis 2012;30(2):148-153.
  31. Gremese E, Ferraccioli G. The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev 2011;10(10):582-9.
  32. Liu Y, Hazlewood GS, Kaplan GG, Eksteen B, Barnabe C. Impact of Obesity on Remission and Disease Activity in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Arthritis Care Res (Hoboken) 2017;69(2):157-65.
  33. George MD, Ostergaard M, Conaghan PG, Emery P, Baker DG, Baker JF. Obesity and rates of clinical remission and low MRI inflammation in rheumatoid arthritis. Ann Rheum Dis 2017;76(10):1743-6.
  34. Vest AR, Wu Y, Hachamovitch R, Young JB, Cho L. The Heart Failure Overweight/Obesity Survival Paradox: The Missing Sex Link. JACC Heart Fail 2015;3(11):917-26.
  35. Lennon H, Sperrin M, Badrick E, Renehan AG. The Obesity Paradox in Cancer: a Review. Curr Oncol Rep 2016;18(9):56.
  36. England BR, Baker JF, Sayles H, Michaud K, Caplan L, Davis LA, et al. Body Mass Index, Weight Loss, and Cause-Specific Mortality in Rheumatoid Arthritis. Arthritis Care Res (Hoboken) 2018;70(1):11-8.
  37. Gonzalez MC, Pastore CA, Orlandi SP, Heymsfield SB. Obesity paradox in cancer: new insights provided by body composition. Am J Clin Nutr 2014;99(5):999-1005.
  38. Cao C, Wang R, Wang J, Bunjhoo H, Xu Y, Xiong W. Body mass index and mortality in chronic obstructive pulmonary disease: a meta-analysis. PLoS One 2012;7(8):e43892.
  39. Escalante A, Haas RW, del Rincon I. Paradoxical effect of body mass index on survival in rheumatoid arthritis: role of comorbidity and systemic inflammation. Arch Intern Med 2005;165(14):1624-9.
  40. Wolfe F, Michaud K. Effect of body mass index on mortality and clinical status in rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012;64(10):1471-9.
  41. Kremers HM, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Prognostic importance of low body mass index in relation to cardiovascular mortality in rheumatoid arthritis. Arthritis Rheum 2004;50(11):3450-7.
  42. Baker JF, Billig E, Michaud K, Ibrahim S, Caplan L, Cannon GW, et al. Weight Loss, the Obesity Paradox, and the Risk of Death in Rheumatoid Arthritis. Arthritis Rheumatol 2015;67(7):1711-7.
  43. Perez-Cano FJ, Castell M. Flavonoids, Inflammation and Immune System. Nutrients 2016;8(10).
  44. Hoensch HP, Weigmann B. Regulation of the intestinal immune system by flavonoids and its utility in chronic inflammatory bowel disease. World J Gastroenterol 2018;24(8):877-81.
  45. Zeinali M, Rezaee SA, Hosseinzadeh H. An overview on immunoregulatory and anti-inflammatory properties of chrysin and flavonoids substances. Biomed Pharmacother 2017;92:998-1009.
  46. Maleki SJ, Crespo JF, Cabanillas B. Anti-inflammatory effects of flavonoids. Food Chem 2019;299:125124.
  47. Chen S, Jiang H, Wu X, Fang J. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes. Mediators Inflamm 2016;2016:9340637.
  48. Yang J, Meyers KJ, van der Heide J, Liu RH. Varietal differences in phenolic content and antioxidant and antiproliferative activities of onions. J Agric Food Chem 2004;52(22):6787-93.
  49. Philip P, Sagaspe P, Taillard J, Mandon C, Constans J, Pourtau L, et al. Acute Intake of a Grape and Blueberry Polyphenol-Rich Extract Ameliorates Cognitive Performance in Healthy Young Adults During a Sustained Cognitive Effort. Antioxidants (Basel) 2019;8(12).
  50. Ganai AA, Farooqi H. Bioactivity of genistein: A review of in vitro and in vivo studies. Biomed Pharmacother 2015;76:30-8.
  51. Dias AT, de Castro SBR, de Souza Alves CC,  Evangelista MG, da Silva LC, Reis DRL, et al. Genistein modulates the expression of Toll-like receptors in experimental autoimmune encephalomyelitis. Inflamm Res 2018;67(7):597-608.
  52. Hu Y, Li J, Qin L, et al. Study in Treatment of Collagen-Induced Arthritis in DBA/1 Mice Model by Genistein. Curr Pharm Des 2016;22(46):6975-81.
  53. Li J, Gang D, Yu X, Hu Y, Yue Y, Cheng W, et al. Genistein: the potential for efficacy in rheumatoid arthritis. Clin Rheumatol 2013;32(5):535-40.
  54. Oliviero F, Scanu A, Zamudio-Cuevas Y, Punzi L, Spinella P. Anti-inflammatory effects of polyphenols in arthritis. J Sci Food Agric 2018;98(5):1653-9.
  55. Chen M, Fu Q, Song X, Muhammad A, Jia R, Zou Y, et al. Preparation of resveratrol dry suspension and its immunomodulatory and anti-inflammatory activity in mice. Pharm Biol 2020;58(1):8-15.
  56. Liu M, Ma F, Wu F, Jiang C, Wang Y. Expression of stilbene synthase VqSTS6 from wild Chinese Vitis quinquangularis in grapevine enhances resveratrol production and powdery mildew resistance. Planta 2019;250(6):1997-2007.
  57. Xia N, Daiber A, Forstermann U, Li H. Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol 2017;174(12):1633-46.
  58. Carter LG, D'Orazio JA, Pearson KJ. Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer 2014;21(3):R209-225.
  59. Lee JH, Wendorff TJ, Berger JM. Resveratrol: A novel type of topoisomerase II inhibitor. J Biol Chem 2017;292(51):21011-22.
  60. Correa MG, Pires PR, Ribeiro FV, Pimentel SP, Cirano FR, Napimoga MH, et al. Systemic treatment with resveratrol reduces the progression of experimental periodontitis and arthritis in rats. PLoS One 2018;13(10):e0204414.
  61. Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clin Rheumatol 2018;37(8):2035-42.
  62. Khan H, Sureda A, Belwal T, Çetinkaya S, Süntar İ, Tejada S, et al. Polyphenols in the treatment of autoimmune diseases. Autoimmun Rev 2019;18(7):647-57.
  63. Mirzaei H, Shakeri A, Rashidi B, Jalili A, Banikazemi Z, Sahebkar A. Phytosomal curcumin: A review of pharmacokinetic, experimental and clinical studies. Biomed Pharmacother 2017;85:102-12.
  64. Al-Suhaimi EA, Al-Riziza NA, Al-Essa RA. Physiological and therapeutical roles of ginger and turmeric on endocrine functions. Am J Chin Med 2011;39(2):215-31.
  65. Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res. 2014;28(5):633-642.
  66. Noorafshan A, Ashkani-Esfahani S. A review of therapeutic effects of curcumin. Curr Pharm Des 2013;19(11):2032-46.
  67. Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, et al. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol 2017;174(11):1325-48.
  68. Daily JW, Yang M, Park S. Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food 2016;19(8):717-29.
  69. Chandran B, Goel A. A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother Res 2012;26(11):1719-25.
  70. Amalraj A, Varma K, Jacob J, Divya C, Kunnumakkara AB, Stohs SJ, et al. A Novel Highly Bioavailable Curcumin Formulation Improves Symptoms and Diagnostic Indicators in Rheumatoid Arthritis Patients: A Randomized, Double-Blind, Placebo-Controlled, Two-Dose, Three-Arm, and Parallel-Group Study. J Med Food 2017;20(10):1022-30.
  71. Jacob J, Amalraj A, Raj KKJ, Divya C, Kunnumakkara AB, Gopi S. A novel bioavailable hydrogenated curcuminoids formulation (CuroWhite) improves symptoms and diagnostic indicators in rheumatoid arthritis patients - A randomized, double blind and placebo controlled study. J Tradit Complement Med 2019;9(4):346-52.
  72. Coradini K, Lima FO, Oliveira CM, Chaves PS, Athayde ML, Carvalho LM, et al. Co-encapsulation of resveratrol and curcumin in lipid-core nanocapsules improves their in vitro antioxidant effects. Eur J Pharm Biopharm 2014;88(1):178-85.
  73. Coradini K, Friedrich RB, Fonseca FN, Vencato MS, Andrade DF, Oliveira CM, et al. A novel approach to arthritis treatment based on resveratrol and curcumin co-encapsulated in lipid-core nanocapsules: In vivo studies. Eur J Pharm Sci 2015;78:163-70.
  74. Huang M, Liang C, Tan C, Huang S , Ying R , Wang Y , et al. Liposome co-encapsulation as a strategy for the delivery of curcumin and resveratrol. Food Funct 2019;10(10):6447-58.